دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Non-invasive diagnosis, antithrombotic treatment, and invasive management of ischaemic heart disease
Filippo Crea
doi : 10.1093/eurheartj/ehac462
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3087–3091
‘Our real work’: medicine and poetry with Dr Adam PossnerÂ
Emma Luisa Hempstead
doi : 10.1093/eurheartj/ehac350
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3092–3093
When one door closesÂ
Adam Possner, M D
doi : 10.1093/eurheartj/ehac182
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Page 3094
Tigray Siege and its impact on cardiology services in Mekelle University Hospital: a call to actionÂ
Abraha Hailu Weldegerima, Hagazi Tesfay, Samuel Berhane, Christian J Leuner
doi : 10.1093/eurheartj/ehac295
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3095–3097
Deciphering a decision support tool (CoDE-HF) to improve the diagnosis of acute heart failureÂ
Rocco Vergallo, Massimo Volpe
doi : 10.1093/eurheartj/ehac372
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3098–3099
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysisÂ
Marco Valgimigli, Pieter C Smits, Enrico Frigoli, Dario Bongiovanni, Jan Tijssen, Thomas Hovasse, Al Mafragi, Willem Theodoor Ruifrok, Dimitar Karageorgiev, Adel Aminian, Stefano Garducci, Bela Merkely, Helen Routledge, Kenji Ando, Josè Francisco Diaz Fernandez, Thomas Cuisset, Fazila Tun Nesa Malik, Majdi Halabi, Loic Belle, Jehangir Din, Farzin Beygui, Atul Abhyankar, Krzysztof Reczuch, Giovanni Pedrazzini, Dik Heg, Pascal Vranckx, MASTER DAPT Investigators
doi : 10.1093/eurheartj/ehac284
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3100–3114
To assess the effects of 1- or ≥3-month dual antiplatelet therapy (DAPT) in high bleeding risk (HBR) patients who received biodegradable-polymer sirolimus-eluting stents for complex percutaneous coronary intervention (PCI) and/or acute coronary syndrome (ACS).
Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary interventionÂ
Luis Ortega-Paz, Dominick J Angiolillo
doi : 10.1093/eurheartj/ehac369
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3115–3117,
Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 studyÂ
Roel S Driessen, Pepijn A van Diemen, Pieter G Raijmakers, Juhani Knuuti, Teemu Maaniitty, S Richard Underwood, Eike Nagel, Lourens F H J Robbers, Ahmet Demirkiran, Martin B von Bartheld, Peter M van de Ven, Leonard Hofstra, G Aernout Somsen, Igor I Tulevski, Ronald Boellaard, Albert C van Rossum, Ibrahim Danad, Paul Knaapen
doi : 10.1093/eurheartj/ehac286
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3118–3128
The diagnostic performance of non-invasive imaging in patients with prior coronary artery disease (CAD) has not been tested in prospective head-to-head comparative studies.
Stress imaging versus fractional flow reserve: what comes first—the chicken or the egg?Â
Patrizio Lancellotti, Yun Yun Go, Alain Nchimi
doi : 10.1093/eurheartj/ehac287
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3129–3131
Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trialÂ
Sashiananthan Ganesananthan, Christopher A Rajkumar, Michael Foley, David Thompson, Alexandra N Nowbar, Henry Seligman, Ricardo Petraco, Sayan Sen, Sukhjinder Nijjer, Simon A Thom, Roland Wensel, John Davies, Darrel Francis, Matthew Shun-Shin, James Howard, Rasha Al-Lamee
doi : 10.1093/eurheartj/ehac260
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3132–3145
Oxygen-pulse morphology and gas exchange analysis measured during cardiopulmonary exercise testing (CPET) has been associated with myocardial ischaemia.
Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moonÂ
Alessandro Spirito, Davide Cao, Roxana Mehran
doi : 10.1093/eurheartj/ehac353
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3145–3147
Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trialsÂ
Thomas A Kite, Sameer A Kurmani, Vasiliki Bountziouka, Nicola J Cooper, Selina T Lock, Chris P Gale, Marcus Flather, Nick Curzen, Adrian P Banning, Gerry P McCann, Andrew Ladwiniec
doi : 10.1093/eurheartj/ehac213
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3148–3161
The optimal timing of an invasive strategy (IS) in non-ST-elevation acute coronary syndrome (NSTE-ACS) is controversial. Recent randomized controlled trials (RCTs) and long-term follow-up data have yet to be included in a contemporary meta-analysis.
Timing of invasive management of NSTE-ACS: is the time up for early management?Â
Paul Guedeney, Holger Thiele, Jean Philippe Collet
doi : 10.1093/eurheartj/ehac212
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3161–3163
The collateral damage of COVID-19 to cardiovascular services: a meta-analysisÂ
Ramesh Nadarajah, Jianhua Wu, Ben Hurdus, Samira Asma, Deepak L Bhatt, Giuseppe Biondi-Zoccai, Laxmi S Mehta, C Venkata S Ram, Antonio Luiz P Ribeiro, Harriette G C Van Spall, John E Deanfield, Thomas F Lüscher, Mamas Mamas, Chris P Gale
doi : 10.1093/eurheartj/ehac227
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3164–3178
The effect of the COVID-19 pandemic on care and outcomes across non-COVID-19 cardiovascular (CV) diseases is unknown. A systematic review and meta-analysis was performed to quantify the effect and investigate for variation by CV disease, geographic region, country income classification and the time course of the pandemic.
The cardiovascular legacy of the COVID-19 pandemicÂ
Ankeet S Bhatt, Muthiah Vaduganathan
doi : 10.1093/eurheartj/ehac256
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3179–3181
Hybrid repair of a giant left subclavian artery aneurysm and arch coarctation in a patient with Larsen syndrome
Haiyue Wang, Yu Zhang, Peng Yang, Jia Hu
doi : 10.1093/eurheartj/ehac327
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Page 3182
Novel technique of sutureless pulmonic valve replacement for quadricuspid pulmonic valve with huge pulmonary artery aneurysm
Kyu Yong Ko, Geu Ru Hong, Seung Hyun Lee
doi : 10.1093/eurheartj/ehac370
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Page 3183
Corrigendum to: Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry
doi : 10.1093/eurheartj/ehac310
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Page 3184
Corrigendum to: Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias
doi : 10.1093/eurheartj/ehac380
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Page 3181
